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Exogenous administration of glucocorticoids is a widely used and efﬁcient tool to investigate the effects
of elevated concentrations of these hormones in ﬁeld studies. Because the effects of corticosterone are
dose and duration-dependent, the exact course of plasma corticosterone levels after exogenous adminis-
tration needs to be known. We tested the performance of self-degradable corticosterone pellets
(implanted under the skin) in elevating plasma corticosterone levels. We monitored baseline (sampled
within 3 min after capture) total corticosterone levels and investigated potential interactions with corti-
costeroid-binding-globulin (CBG) capacity and the endogenous corticosterone response to handling in
Eurasian kestrel Falco tinnunculus and barn owl Tyto alba nestlings. Corticosterone pellets designed for
a 7-day-release in rodents elevated circulating baseline total corticosterone during only 2–3 days com-
pared to placebo-nestlings. Highest levels occurred 1–2 days after implantation and levels decreased
strongly thereafter. CBG capacity was also increased, resulting in a smaller, but still signiﬁcant, increase
in baseline free corticosterone levels. The release of endogenous corticosterone as a response to handling
was strong in placebo-nestlings, but absent 2 and 8 days after corticosterone pellet implantation. This
indicates a potential shut-down of the hypothalamo–pituitary–adrenal axis after the 2–3 days of elevated
baseline corticosterone levels. 20 days after pellet implantation, the endogenous corticosterone response
to handling of nestlings implanted with corticosterone pellets attained similar levels as in placebo-nes-
tlings. Self-degradable pellets proved to be an efﬁcient tool to artiﬁcially elevate circulating baseline cor-
ticosterone especially in ﬁeld studies, requiring only one intervention. The resulting peak-like elevation
of circulating corticosterone, the concomitant elevation of CBG capacity, and the absence of an endoge-
nous corticosterone response to an acute stressor have to be taken into account.
 2008 Elsevier Inc. All rights reserved.1. Introduction
Exogenous administration of glucocorticoids is a widely used
and efﬁcient tool to investigate the effects of elevated concentra-
tions of these hormones. Methods to artiﬁcially elevate glucocorti-
coids include single or repeated injections (e.g. Remage-Healey and
Romero, 2002; Loiseau et al., 2008), adding hormone to the food or
drinking water (e.g. Breuner et al., 1998; Hiebert et al., 2000; Hull
et al., 2007), or implantation of a silastic tube ﬁlled with crystalline
hormone (e.g. Silverin, 1986; Wingﬁeld and Silverin, 1986; Kitay-ll rights reserved.
itute, Luzernerstrasse 6, CH-
. Müller).sky et al., 2001), a gelling material containing hormone (French
et al., 2007), a mini-infusion pump (Donker and Beuving, 1989)
or an osmotic pump (Horton et al., 2007). These various forms of
administration have different advantages and disadvantages. Injec-
tions imply repeated handling with concurrent internal adrenocor-
tical responses when hormone levels should be elevated over days.
While the intake of glucocorticoids with food or water is not inva-
sive, the amount of assimilated glucocorticoids depends on the
quantity of food or water ingested and can vary between individu-
als. Additionally, repeated injections and hormone consumption
are very difﬁcult to apply in free-living animals. Glucocorticoid-
releasing implants or osmotic pumps require only one intervention
followed by the release of a given amount of glucocorticoids over a
longer period of time and are often the method of choice in ﬁeld
studies. However, removal of these implants requires a second
intervention. An alternative method is the implantation of self-
60 C. Müller et al. / General and Comparative Endocrinology 160 (2009) 59–66degradable corticosterone-releasing pellets, which should provide
a constant release by biodegradation of the matrix and do not re-
quire subsequent removal. This method has rarely been used in
experiments with wild bird species until now (e.g. Pravosudov,
2003; Bourgeon and Raclot, 2006; Bonier et al., 2007).
In most studies the effect of corticosterone administration on
circulating corticosterone is not well documented, although the
levels of circulating corticosterone attained and the duration of
the elevation are supposed to be decisive, since the effects of cor-
ticosterone are dose dependent (e.g. Romero, 2004) and the dura-
tion of the exposure to elevated levels is crucial. The time course of
circulating baseline (sampled within 3 min after capture) cortico-
sterone after administering corticosterone in birds has been fol-
lowed in only a few studies by measuring circulating total
corticosterone at a few speciﬁc time points, e.g. after several days
(e.g. Kitaysky et al., 2001). The interactions further up and down-
stream from corticosterone during and after an exogenous cortico-
sterone administration have been investigated predominantly in
mammals (e.g. Feldman et al., 1979; Zhao et al., 1997) and only
rarely in birds. Only one study investigated the effect of corticoste-
rone administration on corticosteroid-binding-globulin (CBG)
(Breuner et al., 2003b). We know of no study examining the re-
sponse to an acute stressor after the period when circulating corti-
costerone was elevated.
The aim of this paper is to report our experiences with self-
degradable corticosterone-releasing pellets in an extended ﬁeld
study with nestling Eurasian kestrels Falco tinnunculus and barn
owls Tyto alba. Speciﬁcally, we investigated (a) the time course of
total circulating corticosterone during 20 days after implantation;
(b) whether CBG capacity and estimated free corticosterone levels
were affected by corticosterone administration, and (c) whether
the response of circulating corticosterone levels to an acute stres-
sor (handling) was affected by corticosterone administration. We
predicted that CBG capacity would increase with elevated cortico-
sterone levels and that the negative feedback regulation would de-
crease the endogenous response to an acute stressor in cort-
nestlings with elevated corticosterone compared to placebo-nes-
tlings. For aim (b) and (c) we were interested in the acute effects
of the implant and in potential mid-term effects after circulating
baseline corticosterone had returned to normal levels.2. Material and methods
2.1. Study species and study sites
The Eurasian Kestrel is a small, diurnal raptor. Usually, the fe-
male starts incubation after laying the third of 4–6 eggs, hence,
the three oldest nestlings have about the same age. The nestlings
stay in the nest for 32–39 days and reach their maximal body mass
around day 23. Fieldwork was performed in North-Western Swit-
zerland (4725’N/750’E), where kestrels raise their young in nest
boxes mounted on agricultural buildings in open rural landscapes.
Mean brood size (± SD) of the investigated broods at the day of
implantation was 4.4 ± 0.96 nestlings, mean hatching date was
on 7 June ± 13 days.
The barn owl is a medium-sized, nocturnal owl species produc-
ing clutches of 2–11 eggs. Incubation starts after laying the ﬁrst
egg and only females incubate. The laying intervals of two to three
days entail a pronounced within-brood age hierarchy. The nes-
tlings reach their maximum body mass with 40 days and ﬂedge
with about 56 days of age. Barn owls were investigated in Western
Switzerland (4649’N/0656’E), where they breed in nest boxes at-
tached on barns and farm buildings. Mean brood size (± SD) of the
investigated broods at the day of implantation was 5.8 ± 1.54 nes-
tlings, mean hatching date was on 3 June ± 33 days.2.2. Experimental corticosterone treatment
The experiment was carried out in 109 kestrel nestlings of 30
broods (13 in 2004 and 17 in 2005) and 208 barn owl nestlings
of 73 broods (33 in 2004, 19 in 2005, 21 in 2006). Hatching date
was determined through regular nest box controls.
Two randomly selected nestlings out of the four oldest within a
brood were implanted with a self-degradable corticosterone-
releasing pellet on nestling day 13 (mean age ± SD: 13.2 ± 1.4 days)
in the kestrel and nestling day 25 (mean age 27 ± 5 days) in barn
owl nestlings. Pellets designed for a 7-day-release in rodents were
obtained from Innovative Research of America (Sarasota, FL, USA.).
Because kestrels were lighter in body mass (mean ± SD: 165 ± 22 g
at implantation) than barn owls (294 ± 69 g at implantation), we
implanted a 10 mg corticosterone pellet (cat # C-111) in nestling
kestrels and a 15 mg corticosterone pellet (cat # G-111) in nestling
barn owls. The other two of the four oldest siblings were implanted
with a corresponding placebo pellet, creating two treatment
groups (cort- and placebo-nestlings). Before implantation, body
mass (kestrels: t = 1.44, df = 107, p = 0.153; barn owls: t = 0.71,
df = 206, p = 0.478), nestling age (kestrels: t = 0.56, df = 107,
p = 0.577; barn owls: t = 0.28, df = 206, p = 0.783) and the propor-
tion of the sexes (kestrels: {2 = 0.01, df = 1, p = 0.922; barn owls:
{2 = 0.09, df = 1, p = 0.752) did not differ between cort- and pla-
cebo-nestlings. The pellets were placed under the skin of the ﬂank
above the knee through a small incision. The pellets are very sen-
sitive to alcoholic solvents, even when seemingly evaporated
(based on our own observations in previous trials, and personal
communication by the provider). Therefore, to prevent accelerated
corticosterone release, the skin was not disinfected. The incision
was closed with tissue adhesive (Histoacryl, Braun, Germany). If
more than four siblings were present, the ﬁfth and following were
not implanted. All methods described in this study were approved
by the Swiss committee for animal research (animal experiment
permit no 274 from the Cantonal Veterinarian Ofﬁce of Baselland
for kestrels and no 1736 from the Veterinarian Ofﬁce of Vaud for
barn owls).
Pellet implantation and corticosterone treatment did not affect
survival of nestlings. In kestrels nestlings, between nestling day 13
and ﬂedging, 54 of 56 placebo-nestlings (96.4%) and 60 of 61 cort-
nestlings (98.4%) survived, while 242 of 260 nestlings not treated
with a pellet survived (93.1%; nestlings of other broods at our
study site during the study years which were only measured and
blood sampled). In barn owls, 40 of 43 cort-nestlings (93.0%) and
42 of 43 placebo-nestlings (97.7%) survived until ﬂedging, while
159 of 179 non-treated nestlings (88.8%) survived until ﬂedging.
All differences in survival between cort-implanted, placebo-im-
planted and non-implanted birds were not signiﬁcant (kestrel:
Pearson {2 = 3.12, df = 2, p = 0.210; barn owl: Pearson {2 = 3.57,
df = 2, p = 0.168).
2.3. Blood sampling
We took baseline blood samples in kestrel nestlings 3 days be-
fore implantation, on the day of implantation (day 0) and 3 and 8
days after implantation. In a subgroup of kestrel nestlings we took
an additional baseline sample 1 or 2 days after implantation. All
baseline samples were taken within 3 min after taking nestlings
out of the nest box in batches of two. There was no effect of batch
number or the time between ﬁrst arrival and bleeding on baseline
corticosterone (F = 0.57, df = 2, p = 0.567). In barn owls we col-
lected a blood sample within 3 min after having opened the nest
box on the day of implantation and 6 and 20 days after implanta-
tion (blood samples taken after 3 min were not used for this
study); a subgroup was also sampled 2 or 3 days after implanta-
tion. In addition, we had baseline samples of 5 cort-nestlings of 4
Fig. 1. Equilibrium saturation binding curve demonstrating speciﬁc binding of 3H-
corticosterone to (A) Eurasian kestrel and (B) barn owl plasma as a function of
increasing concentrations of radiolabeled corticosterone. Points indicate means ±
SE. The inlay is the Scatchard-Rosenthal replot of the data.
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whether corticosterone levels were not pharmacologically high,
but we did not include them in the statistical tests, because the
corresponding placebo samples were missing. After taking the ﬁrst
blood sample, the nestlings were measured, weighed and then held
in a cloth bag. The adrenocortical response to handling was as-
sessed by taking a second blood sample about 17 min (mean ± SD:
16.9 ± 1.4 min, range: 15–22) after taking the nestlings out of the
nest box in kestrels and 19 min (19.13. ± 2.92 min, range: 15–25)
in barn owls. Handling-induced corticosterone levels did not vary
within these time ranges (Placebo-nestlings: p > 0.242). Blood
was sampled by puncturing the alar vein and collected in heparin-
ized capillary tubes. Within 30 min, the blood was centrifuged in
Eppendorf tubes and the plasma immediately stored in liquid
nitrogen in the ﬁeld and at 20 C once in the laboratory.
2.4. Corticosterone assay
Plasma corticosterone concentration was determined using an
enzyme immuno assay (Munro and Stabenfeldt, 1984; Munro
and Lasley, 1988). Five microliter of plasma was added to 195 ll
water, and from this solution we extracted corticosterone with
4 ml dichloromethane, which was re-dissolved in phosphate buffer
and measured in triplicates in the enzyme immunoassay. The dilu-
tion of the corticosterone antibody (Chemicon; cross-reactivity:
11-dehydrocorticosterone 0.35%, Progesterone 0.004%, 18-OH-
DOC 0.01%, Cortisol 0.12%, 18-OH-B 0.02% and Aldosterone 0.06%)
was 1:8’000. HRP (1:400’000) linked to corticosterone served as
enzyme label and ABTS as substrate. The concentration of cortico-
sterone in plasma samples was calculated by using a standard
curve run in duplicate on each plate. Plasma pools from chickens
with two different corticosterone concentrations were included
as internal controls on each plate. In 38 cases the concentration
was below the detection threshold, and in this case the determina-
tion was repeated with 10 ll plasma. If the concentration was still
below the detection threshold (27 samples), the value of the lowest
detectable concentration (1 ng ml1) was assigned. Intra-assay
variation ranged from 4.5% to 13.4% and inter-assay variation from
9.6% to 23.0%, depending on the concentration of the internal con-
trol and the year of determination.
2.5. Corticosteroid-binding-globulin
The afﬁnity and capacity of corticosteroid-binding-globulin
(CBG) was measured with a radioligand-binding assay with triti-
ated corticosterone following Breuner et al. (2003a). For point sam-
ple analysis, plasma (10–15 ll in the kestrel, 5 ll in the barn owl)
was stripped of endogenous steroids with two parts of dextran-
coated charcoal (0.1% dextran, 1% Norit A charcoal in 50 mM Tris)
for 30 min at room temperature. Outside this stripping procedure,
the plasma was maintained below 4 C. The ﬁnal assay dilution of
kestrel plasma samples was 1:99, those of the barn owl samples
1:450. The binding assay was carried out in 50 nM Tris buffer at
4 C and terminated after 2 h. 1 h before ﬁltering, glass ﬁber ﬁlters
(Whatman) were soaked in 25 nM Tris with 0.3% polyethyleneim-
ine. After ﬁltration, ﬁlters were rapidly rinsed with three rinses of
3 ml ice-cold 25 nM Tris. Point sample analysis was performed
with individual plasma samples, for the saturation analyzes pooled
samples were run. For the saturation analyzes, 0.25–12 nM [3H]
Corticosterone were incubated with pooled plasma of each species
with and without 1 lM unlabeled corticosterone. 20 nM [3H] Cor-
ticosterone was employed to estimate CBG capacity in individual
birds. Afﬁnity estimates obtained from equilibrium saturation
analysis (Kd = 4.59 and 4.11 nM in kestrels and barn owls, respec-
tively, Fig. 1A and B) indicated that this ligand concentration occu-
pies 80% of total binding sites. For analysis, the samples werecorrected to 100% capacity within each assay. The intra-assay var-
iation was 5.7% and 7.1%, the inter-assay variation 7.58% and 17.1%
(kestrel and barn owl samples determined separately).
The equation of Barsano and Baumann (1989) was used to esti-
mate free corticosterone titers from total corticosterone concentra-
tions and CBG binding parameters
Hfree ¼ 0:5 Htotal  Bmax  1=Ka½ 

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðBmax  Htotal þ 1=KaÞ2 þ 4ðHtotal=KaÞ
q
ð1Þ
where Hfree is free Hormone, Htotal is total Hormone, Bmax is total
binding capacity of CBG, and Ka = 1/dissociation constant (Kd) (all
values in nM). Corticosterone was analyzed in all baseline and han-
dling induced blood samples, CBG capacity was measured in all
baseline kestrel and barn owl samples and a subsample of the han-
dling induced kestrel samples (a subsample of day 10, all samples of
day 21).
2.6. Statistical analyses
To analyze the overall effect of corticosterone treatment on cir-
culating corticosterone we performed mixed models (REML, Gen-
stat 10) separately with total corticosterone, CBG capacity and
free corticosterone as dependent variables. We included treatment
(corticosterone versus placebo) and time after implantation (num-
ber of days after implantation) and their interaction as ﬁxed factors
and nestling identity nested in broods as random factors to correct
for the dependence of siblings within a brood.
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dling was analyzed separately for total and free corticosterone
and CBG capacity by running a repeated measures analysis includ-
ing baseline and stress-induced levels of those days with two blood
samples per individual. The model included time after implanta-
tion, treatment, blood sample (baseline versus handling-induced)
and their interactions as ﬁxed factors, and nestling identity nested
in brood as random factors. To compare corticosterone levels of
baseline and handling-induced blood samples and CBG capacity
between treatment groups at the different sampling days, we per-
formed post-hoc tests for each day separately. Treatment was in-
cluded as ﬁxed and brood as random factor in these mixed
models and signiﬁcance levels were adjusted according to Bonfer-
roni (Sokal and Rohlf, 2000). Kestrel and barn owl data were ana-
lyzed in separate models.
3. Results
3.1. Effect of corticosterone pellets on baseline total and free
corticosterone levels and CBG capacity
Implanting a corticosterone pellet had a highly signiﬁcant effect
on the plasma concentration of total corticosterone in both species
(Table 1 and 2). Before implantation, there was no difference in to-
tal corticosterone level between cort- and placebo-nestlings in
both species (Fig. 2A and B). Total corticosterone in kestrel cort-
nestlings was signiﬁcantly elevated over placebo-nestlings 1 day
after implantation (post-hoc test: F = 39.14, df = 1, 10.4, p < 0.001,
Fig. 2A, Fig. 3A, range: 29.78–63.80 ng/ml), and tended towards
signiﬁcance 2 days after implantation (F = 7.92, df = 1, 4.6,
p = 0.037, not signiﬁcant at the Bonferroni-corrected p-level of
0.013); corticosterone levels were indistinguishable from those of
placebo-nestlings 3 and 8 days after implantation. In barn owl nes-
tlings, total corticosterone in cort-nestlings was signiﬁcantly in-
creased 2 days after implantation (F = 66.78, df = 1, 80.0,
p < 0.001, Fig. 2B, Fig. 3B, range 2 days after implantation: 8.11–
118.03 ng/ml) and returned to the level of placebo-nestlings 3, 6
and 20 days after implantation (p > 0.161). The ﬁve values of
cort-nestlings 1 day after implantation (range 10.7–48.1 ng/ml)
indicated that levels were not higher than 2 days after
implantation.
CBG capacity in kestrel nestlings did not signiﬁcantly vary with
time or treatment (Table 1), and CBG capacity was not signiﬁcantly
elevated on day 1 and 2 after cort-implantation (Fig. 2C; 1 day:
F = 0.80, df = 1, 13.0, p = 0.386, day 2: F = 1.58, df = 1, 2.3,
p = 0.335). In barn owl nestlings, there was an overall effect of
treatment and time and their interaction on CBG capacity (Table
2, Fig. 2D). CBG capacity of barn owl cort-nestlings was signiﬁ-
cantly elevated 2 days after implantation (F = 37.13, df = 1, 69.7,
p < 0.001) and indistinguishable from placebo-nestlings 3, 6 and
20 days after implantation.
Estimated free corticosterone levels varied with time and treat-
ment group depending on time after implantation in both speciesTable 1
Effect of corticosterone pellets on plasma levels of total baseline corticosterone, CBG capaci
nestlings implanted with a corticosterone pellet and 53 nestlings implanted with a placebo
and 8 days after implantation from all nestlings and 1 or 2 days after implantation from 2
given with nestling identity nested in broods as random factors.
Total corticosterone
df F statistic F pr
Time after implantation 5, 438.8 29.83 <0.001
Treatment group 1, 433.5 7.34 0.007
Time after implantation  Treatment group 5, 429.7 33.04 <0.001(Table 1 and 2). There was no difference between the treatment
groups before implantation in both species (Fig. 2E and F). In kes-
trels, although the interaction term time after implantation x treat-
ment was highly signiﬁcant (Table 1), the Bonferroni-corrected
post-hoc tests indicated just no signiﬁcant difference between
cort-nestlings and placebo-nestlings one day after implantation
(F = 5.33, df = 1, 13.0, p = 0.038, Fig. 2E, not signiﬁcant at the Bon-
ferroni-corrected p-level of 0.013), and no difference between the
treatment groups 2, 3 and 8 days after implantation (p = 0.236,
0.847 and 0.072, respectively). In barn owl nestlings, free cortico-
sterone of cort-nestlings was signiﬁcantly elevated two days after
implantation, (F = 26.06, df = 77.8, p < 0.001), while 3, 6 and 20
days after implantation there was no difference between the treat-
ment groups (p = 0.657, 0.153 and 0.733, respectively, Fig. 2F).
3.2. Effect of corticosterone pellets on handling-induced total and free
corticosterone levels and CBG capacity
In both species, total and free corticosterone levels depended on
time after implantation, treatment group and blood sample (base-
line versus handling-induced) (interaction time  treatment
group  blood sample p < 0.001, Table 3).
Placebo-nestlings of both species showed a marked increase of
total plasma corticosterone levels as a response to handling. In
cort-nestlings 2 days after implantation (barn owl, Fig. 4B), when
baseline total corticosterone levels were elevated, plasma cortico-
sterone levels increased only little as a response to handling and
reached similar levels as in placebo-nestlings (treatment:
F = 2.33, df = 1, 120.8, p = 0.130). In cort-nestlings 8 days after
implantation (kestrel, Fig. 4A), when baseline levels were low
again, the adrenocortical response to handling was virtually absent
(interaction time after implantation  treatment group  blood
sample p < 0.001, Table 3, Fig. 4A). In barn owl nestlings 20 days
after implantation, when baseline levels were similar in both treat-
ment groups, cort-nestlings reached similar handling-induced lev-
els as the placebo-nestlings (F = 3.99, df = 1, 37.6, p = 0.053,
Fig. 4B).
4. Discussion
4.1. Effect of corticosterone pellets on total baseline corticosterone
levels
The self-degradable corticosterone pellets clearly increased cir-
culating total baseline corticosterone levels in kestrel and barn owl
nestlings 1–3 days after implantation compared with placebo-nes-
tlings. With the 10 mg and 15 mg 7-day-release pellets used in this
study, the increase in corticosterone levels was within the range
reached by handling before the treatment (kestrel nestlings 8–
50 ng/ml after 17 min; barn owl nestlings 10–110 ng/ml after
19 min) and therefore, within the physiological range. Although
the increase in corticosterone levels induced by the pellets varied
between individuals, they were clearly higher than in placebo-nes-ty and estimated free corticosterone in kestrel nestlings. Treatment group refers to 56
pellet. Time after implantation refers to blood samples taken 3 and 0 days before and 3
5 nestlings (470 measurements in total). The results from a mixed model analysis are
CBG capacity Free corticosterone
df F statistic F pr df F statistic F pr
5, 308.2 1.44 0.210 5, 320.6 14.37 <0.001
1, 73.7 0.02 0.896 1, 78.2 1.26 0.265
5, 314.5 2.05 0.071 5, 323.5 15.78 <0.001
Table 2
Effect of corticosterone pellets on plasma levels of total baseline corticosterone, CBG capacity and estimated free corticosterone in barn owl nestlings. Treatment group refers to
96 nestlings implanted with a corticosterone pellet and 91 nestlings implanted with a placebo pellet. Time after implantation refers to blood samples taken at day 0 (n = 144), 2
(n = 92), 3 (n = 28), 6 (n = 47) or 20 days (n = 78) after implantation (389 measurements in total). The results from a mixed model analysis are given with nestling identity nested
in broods as random factors.
Total corticosterone CBG capacity Free corticosterone
df F statistic F pr df F statistic F pr df F statistic F pr
Time after implantation 4, 362.3 28.50 <0.001 4, 270.1 10.52 <0.001 4, 355.2 7.99 <0.001
Treatment group 1, 367.0 46.47 <0.001 1, 113.7 18.59 <0.001 1, 339.4 9.19 0.003
Time after implantation  Treatment group 4, 345.8 28.39 <0.001 4, 288.8 10.15 <0.001 4, 325.5 8.10 <0.001
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C. Müller et al. / General and Comparative Endocrinology 160 (2009) 59–66 63tlings (Fig. 3A and B). However, baseline corticosterone levels were
not elevated to a constant level, but peaked 1–2 days after implan-
tation, dropped to a lower level 2 days after implantation (in the
kestrel) and had almost reached placebo-levels 3 days after
implantation. Thus, with these pellets, corticosterone levels were
elevated for a shorter period than the 7 days indicated by the pro-
vider and similar ﬁndings were obtained in house sparrows (C.W.B.unpublished data). There are two possible explanations. First, the
corticosterone contained in the pellet may have been released very
fast, resulting in peak-like levels higher than intended. It is possi-
ble, that the pellet matrix is metabolized faster and corticosterone
released in a shorter time period in birds than in mammals, for
which the pellet was designed originally. A second explanation is
that through the internal negative feedback the release of endoge-
1To
ta
l c
or
tic
os
te
ro
ne
 [n
g/
m
l]
0
10
20
30
40
50
60
70
1
0
20
40
60
80
100
120
140
Kestrel Barn owl
B A 
Time after implantation [d] 
2 2
Fig. 3. Individual variation of baseline circulating total corticosterone levels during
the two days after pellet implantation in (A) kestrel and (B) barn owl nestlings. All
data points are from different individuals (ﬁlled symbols: Corticosterone, empty
symbols: Placebo).
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metabolized. The ﬁnding that the glucocorticoid response to han-
dling was strongly reduced up to 8 days after implantation may
suggest that the negative feedback mechanism was indeed in oper-Table 3
Effect of corticosterone pellets on total baseline and handling induced corticosterone levels
corticosterone or a placebo pellet. Time after implantation in the kestrel refers to blood sam
and, in the barn owl, to blood samples taken at day 0 (n = 75), and 2 (n = 158) or 20 days
3 min) and the handling-induced sample (taken on average 17 (kestrel) or 19 min (barn
identity nested in broods as random factors.
Total corticostero
Kestrel
df
Time after implantation 1, 321.7
Blood sample 1, 313.9
Treatment group 1, 82.6
Time after implantation  Blood sample 1, 313.9
Time after implantation  Treatment group 1, 322.9
Blood sample  Treatment group 1, 313.9
Time after implantation  Blood sample  Treatment group 1, 314.0
BL HI  BL  HI
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Fig. 4. Baseline (BL) and handling-induced (HI) plasma levels of total corticosterone i
implantation of a corticosterone-releasing pellet. Baseline samples were taken within 3 m
and 19 min in the barn owl. Indicated are means ± SE of a sample size of 36–51 kestrel an
nestlings). The pellet was implanted on day 0, which corresponded to an age of 13 daysation (see below). Future studies, using pellets with labeled corti-
costerone, are needed to determine the relative amounts of
endogenous and exogenous corticosterone in the blood and, thus,
the importance of the internal negative feedback mechanism to
regulate plasma levels of corticosterone after external
administration.
In a study implanting silastic tubes ﬁlled with corticosterone in
starlings Sturnus vulgaris and black-legged kittiwakes Rissa tridac-
tyla, plasma corticosterone levels also had decreased to near pla-
cebo-levels 3 or 5 days after implantation (Romero et al., 2005;
Angelier et al., 2007), also indicating a potential negative feedback
regulation reducing the adrenocortical corticosterone release after
some days. Studies using other techniques to administer cortico-
sterone unfortunately do not present the time course of circulating
corticosterone after administration. Usually, the resulting circulat-
ing corticosterone levels were measured only once at varying time
points after the beginning of administration, which prevents the
comparison of the time course of corticosterone levels between
different methods.
The variation between individuals in baseline corticosterone
levels 1–2 days after implantation was quite large (Fig. 3). Similar
data from published studies using other ways of administering
corticosterone are not known to us. It is well established that
baseline and handling-induced corticosterone levels (not induced
by implants) vary considerably between individuals (e.g. Cockrem
and Silverin 2002), hence, there is considerable individual varia-
tion in the functioning of the HPA axis that may also hold whenin kestrel and barn owl nestlings. Treatment group refers to nestlings implanted with a
ples taken 3 days before implantation (n = 106) and 8 days after implantation (n = 103)
(n = 51) after implantation. Blood sample refers to the baseline sample (taken within
owl) after capture). The results from a mixed model analysis are given with nestling
ne
Barn owl
F statistic F pr df F statistic F pr
7.50 0.007 2, 430.2 8.71 <0.001
155.47 <0.001 1, 395.1 367.96 <0.001
18.32 <0.001 1, 122.9 3.45 0.066
9.67 0.002 2, 396.1 23.05 <0.001
39.94 <0.001 2, 476.5 1.15 0.319
10.75 0.001 1, 395.2 20.90 <0.001
29.15 <0.001 2, 396.2 8.25 <0.001
BL HI BL HI  BL  HI
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n (A) kestrel and (B) barn owl nestlings before and 8 days or 2 and 20 days after
in after capture and handling-induced samples after a mean of 17 min in the kestrel
d 26–81 barn owls nestlings per time point and treatment group (cort- and placebo-
in kestrels and about 27 days in barn owls.
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in corticosterone levels after implantation in barn owls depends
on environmental conditions (Almasi et al., unpublished data)
and are correlated with a genetically determined color trait (Alm-
asi et al., unpublished data). Hence, the ability to buffer adminis-
tered corticosterone seems to be an interesting individual trait in
itself.
4.2. Effect of corticosterone pellets on CBG capacity and free baseline
corticosterone levels
Concurrent to the increased corticosterone levels, the pellets
also increased CBG capacity in barn owl nestlings and tended to in-
crease CBG capacity (small sample size) in kestrel nestlings. This
corresponds to increased plasma CBG in house sparrows Passer
domesticus and serum CBG in mouse pups after glucocorticoid
administration (Zhao et al., 1997; Breuner et al., 2003b), but is in
contrast to a decrease in CBG production and secretion in rats after
glucocorticoid administration (Feldman et al., 1979). It is possible,
that the increase in CBG capacity serves to protect partly from the
deleterious interferences of high free corticosterone levels with
postnatal morphological and cognitive development (Kitaysky
et al., 2003, Müller et al., unpublished data). However, the course
of free baseline corticosterone correlated strongly with total base-
line corticosterone levels, and the peak in total corticosterone con-
centration after pellet implantation was buffered only to a small
degree by the simultaneously elevated CBG capacity. We did not
ﬁnd any impact of the corticosterone pellets on CBG capacity after
the peak of circulating baseline corticosterone.
4.3. Effect of corticosterone pellets on the adrenocortical response to
handling
There was only a small adrenocortical response to handling two
days after corticosterone pellet implantation in barn owl nestlings
and virtually no adrenocortical response to handling 8 days after
corticosterone pellet implantation in kestrel nestlings. This can
be explained by the negative feedback mechanism controlling cir-
culating corticosterone levels (e.g. Keller-Wood and Dallman,
1984; McEwen et al., 1986). The negative feedback can occur as a
rate-sensitive fast feedback and a level-sensitive delayed feedback
(Dallman and Yates, 1969). The delayed feedback begins approxi-
mately 30 min following glucocorticoid elevation and extends for
days. The duration of the subsequent inhibition of the axis depends
on the absolute concentration of the steroids, thus may extend be-
yond the period of hormone administration (e.g. Abe and Critch-
low, 1980; Sapolsky et al., 1986).
An attenuated adrenocortical response to an acute stressor, as
we observed 2 days after implantation in barn owls, occurs when
the animal is already under chronic stress as provoked here by cor-
ticosterone administration. As a result of a rate-sensitive fast feed-
back the hypothamalo–pituitary–adrenal axis shuts down and is
not capable of mounting a response to an acute stress (Romero,
2004). One example in free-living birds is the absence of any fur-
ther corticosterone elevation to capture and handling in a seabird,
when a severe storm had already substantially increased circulat-
ing corticosterone (Smith et al., 1994). The absence of an adreno-
cortical response to handling in kestrel nestlings eight days after
corticosterone pellet implantation (when baseline total corticoste-
rone levels were not elevated anymore) may be explained by an
extension of a level-sensitive delayed feedback. Alternatively, it
may be explained by the continuous release of corticosterone from
the pellet provoking the shut-down of the hypothamalo–pituitary–
adrenal axis, as mentioned above.
Twenty days after corticosterone pellet implantation, the HPA
axis seemed to have recovered from the corticosterone manipula-tion. As a response to handling barn owl cort-nestlings showed a
similar increase in circulating total corticosterone levels as pla-
cebo-nestlings.
5. Conclusions
Self-degradable pellets are an efﬁcient tool to artiﬁcially elevate
corticosterone levels with one intervention. The dose and dura-
tion-dependent effects of corticosterone require the monitoring
of the resulting circulating corticosterone levels. It is to be ex-
pected, that the release from pellets, and possibly from other im-
plants, is not constant over time or that a delayed feedback sets
in after a few days which both result in different plasma levels,
and thus possibly different effects, of corticosterone at different
stages during the experiment. The plasma levels resulting from
corticosterone administration can be monitored in a subgroup
within the experiment, in an additional group of implanted control
animals or in a preliminary study. However, since the HPA axis can
vary with season, life history stage, environmental conditions, age
and sex (e.g. Wingﬁeld et al., 1994; Kitaysky et al., 1999; Romero,
2002; O’Reilly and Wingﬁeld, 2003; Love and Williams, 2008), any
additional group should closely match the experimental groups
and live under similar conditions and at the same time or season.
Indeed, there is individual variation in corticosterone levels as a re-
sponse to pellet implantation depending on baseline levels (own
unpublished data) and nutritional conditions (Almasi et al., unpub-
lished data).
When using self-degradable corticosterone pellets, no alcohol
or similar solvent should be used during implantation, because
even if seemingly evaporated, alcohol can strongly increase the
release of corticosterone from the pellet. We also recommend
to carefully determine the dosage of the pellet in test birds to
avoid pharmacological levels during the ﬁrst days after
implantation.
The interactions of exogenous corticosterone with the negative
feedback mechanism and the response to an acute stressor have to
be taken into account in future studies. An increase in CBG capacity
provoked by corticosterone administration results in an attenuated
increase in circulating free baseline corticosterone levels compared
with total levels, which maymodify the effects of corticosterone on
the animal.
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